KCT0003301
Completed
未知
A 8 week, randomized, double-blind, placebo-controllled clinical trlial for the evaluation of the efficacy and safety of weissella cibaria CMU on halitosis.
ConditionsDiseases of th respiratory system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of th respiratory system
- Sponsor
- Dankook University
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Male and female aged 20 to over 70
- •2\) A person with a score of 2 or more in the bad taste sensory evaluation (OLT) and a VSC
- •concentration (H2S, CH3SH, (CH3\) 2S) of 1\.5ng or more
- •3\) The person who agrees to participate in this test and who has voluntarily signed the written
- •agreement (or legal representative)
Exclusion Criteria
- •1\) Those who are currently being treated or have a history of systemic disease (liver disease, renal
- •disease, Sjogren's syndrome, rheumatic disease) that may cause bad breath (however, taking
- •into consideration the condition of the subject,
- •2\) Persons with severe dental disease (periodontal disease, dental caries, dry mouth) (dental caries in
- •the dental caries test may be included in the test, except when more than one dental caries)
- •3\) Those with uncontrolled hypertension (160 / 100mmHg or higher, after 5 minutes of test subjects
- •4\) diabetic patients taking fasting blood glucose levels greater than 126 mg / dl, randomized blood
- •glucose levels greater than 200 mg / dl, or taking oral hypoglycemic agents or insulin
- •5\) AST (GOT) or ALT (GPT) blood pressure is three times higher than the normal upper limit of the
- •institution
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
APGP for the evaluation of efficacy on immune function and immune cell activatioNot ApplicableKCT0002551Yonsei University100
Recruiting
Not Applicable
A 8 week, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of IRT5 probiotics on atopic dermatitis in childreDiseases of the skin and subcutaneous tissueKCT0000914Korea Yakult Corporation110
Completed
Not Applicable
A 8 week, randomized, double-blind, placebo-controlled clinical trial of Enzymatic Hydrolysate of Skipjack Tuna Cooking Drip for the evaluation of efficacy and safety on immune functioNot ApplicableKCT0002136Yonsei University100
Completed
Not Applicable
Clinical trial for the evaluation of the efficacy and safety of live or killed Lactobacillus sakei Probio65 on atopic dermatitis in childreDiseases of the skin and subcutaneous tissueKCT0003928Probionic90
Recruiting
Not Applicable
The efficacy and safety of oraCMU on oral healthKCT0004291Seoul National University Dental Hospital100